GLENVIEW CAPITAL MANAGEMENT, LLC
•CIK: 1138995•Filing: Q4 2025
Glenview Capital Management, LLC, led by the seasoned investor team of Jonathan Golub and team, is known for its concentrated, high-conviction investment strategy, currently managing $4.9 billion in assets with a focus on healthcare and technology sectors. Recently, the fund has made notable moves by adding holdings such as HYG, DOCN, and AMD, while exiting SPY and UHS, and achieving significant gains with additions like CNC (+475%) and BFLY (+184%).
Total AUM
$4.7B
+ $219.6M in options
QoQ Performance
+14.1%
Positions
53
+ 2 options
Top 10 Concentration
60.5%
Latest Filing
Q4 2025
Top Holdings Allocation
CVS
TEVA
GPN
THC
CVS13.2%
TEVA10.6%
GPN9.3%
THC8.0%
AMZN4.3%
GTM4.1%
HYG2.9%
VTRS2.8%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other72.8%
Healthcare18.4%
Consumer5.4%
Technology3.4%
🚪 Exited Positionssold since Q3 2025
+10 more exited positions
Changes from Q3 2025
NEW18 new positions
↑24 increased
↓9 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023